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Abstract 
Cocaine is one of the most widely used illicit substances in the world and has an 
addiction rate comparable to opioids. Early Life Stress (ELS) has been shown to have a profound 
influence on the development of an individual, showing strong correlations to the development 
of psychiatric disorders and psychostimulant abuse. Adolescents in particular are at a high risk 
for the abuse of psychostimulants such as cocaine. Previous studies have individually described 
the correlation between cocaine addiction and anxiety, and the correlation between ELS and 
cocaine addiction. Rats who have experienced some form of ELS have shown a higher levels of 
self-administration, but the anxiety resulting from addiction and ELS has not been observed. 
This study sought to examine the effects of ELS and/or adolescent cocaine exposure on 
anxiety-like behavior, as measured by the Elevated Plus Maze (EPM) and Open Field tests in 
rats. Due to complications in maternal separation and behavioral sensitization to cocaine, the 
relationship these variables have on expressed anxiety-like behavior is unclear.    
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Introduction 
Substance abuse and anxiety comorbidity 
With an addiction rate comparable to opioids, cocaine and cocaine-derived drugs prove to 
be some of the most widely used illicit substances in the world. The SAMHSA 2014 National 
Survey on Drug Use and Health revealed that approximately 1.5 million people in the US have 
used cocaine (either in the powder cocaine form or crack cocaine form). Psychostimulants such 
as cocaine have been shown to greatly affect the reward neural circuitry pathway as well as the 
brain areas most associated with learning and memory, and thus can develop strong drug-seeking 
behavior when stimulants are used chronically (Taylor, 2013). Rat models of cocaine addiction 
have indicated that during a period of abstinence, an individual addicted to cocaine can express 
increased levels of anxiety, making relapse all the more likely even when in a treatment program 
(Hage et al., 2012). As well as having high rates of addiction, psychostimulants also tend to 
follow a pattern of behavioral sensitization, meaning continued substance exposure will elicit 
greater changes in behavior without an increase in the amount of substance used.  
Substance abuse and anxiety disorders are two very commonly comorbid conditions, and 
have been the subject of intense psychiatric study (Smith and Book, 2008). Smith and Book also 
suggest in their review of the comorbidity of  Substance Use Disorder (SUD) and Anxiety 
Disorders (ADs), that these two conditions develop and are maintained in tandem. A model of 
co-development would suggest that SUD can develop due to a pre-existing AD, and that an AD 
can develop due to the acquisition of substance dependence. Psychostimulants, such as cocaine, 
tend to follow this comorbid trend quite closely, as their abuse tends to incite a euphoric rush. 
Once the euphoria comes to an end, and the effects of the psychostimulant have worn off, the 
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individual can be left with residual symptoms of anxiety. This phenomenon presents a problem 
to those suffering from any form of substance use disorder, as the increased level of anxiety 
induced by the lack of exposure to his or her drug of abuse would act as a source of 
psychological encouragement to continue a pattern of abuse. Acute psychological stress has has 
also been demonstrated to significantly increase drug-craving behavior (Sinha, Catapano, & 
O’Malley, 1999). When acute stress increases drug-craving behavior, the stressor begins to feed 
into the cycle of addiction, which likely induces a cycle of stress and anxiety as well. If an 
individual were to express a heightened stress response, this issue of addiction could be all the 
worse. The correlation between anxiety disorders and SUD has been documented to be 
significantly positive, which clearly alludes the detrimental cycle that surrounds SUD (Brady et 
al., 2010). With such a strong correlation between ADs and SUDs, it becomes apparent that these 
two disorders need to be studied in tandem as well as suggesting that their influences on each 
other need to be defined. 
Early Life Stress 
Early Life Stress (ELS) has been shown to have profound influence on the development 
of an individual, showing strong correlations with the development of psychiatric disorders and 
significantly altered biochemical markers. One of the most prominent biomarkers in the 
evaluation levels of stress and anxiety is the presence of corticotropin-releasing factors (CRF). 
Corticotropin-releasing factor is the primary regulators of the Hypothalamic-Pituitary-Adrenal 
(HPA) axis (Smith and Vale 2006, Syed and Nemeroff, 2017). CRF has been demonstrated as 
having strong influences on the psychophysiological responses to stress, going as far as to 
change the eating and sleep patterns of rats when CRF was injected into their central nervous 
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system (Syed and Nemeroff, 2017). When The HPA axis consistently releases CRF to the point 
of HPA axis dysregulation, as is consistent with the current understanding of chronic stress, brain 
development can be significantly impaired. Chronic stress during early stages of development 
have also been demonstrated to significantly impact the development of the HPA axis. 
Individuals with this altered HPA axis have been shown to a significantly altered response to 
stressors compared to individuals who never experienced early life stress (van Bodegom, 2017). 
The resulting impairment can include the myelination of various different neurological structures 
( ​Brietzke, 2012)​. Any impairment in neurological development has the potential to have a much 
greater impact when the impairment occurs early in life, such as in childhood. Magnetic 
resonance images comparing the brains of school-aged children to those of adults have revealed 
a significant increase in myelination during childhood and adolescence (Jernigan et al., 2011), 
and if this period of increased myelination were to be interrupted by a disruption of the HPA 
axis, the resulting effects have the potential to be both long lasting and detrimental. The 
biological impacts of ELS do not only impact the brain however, as it the experienced trauma or 
neglect has been shown to have fairly extensive impacts on the immune system (Elwenspoek, 
2017). ELS has been shown to have a lasting impact on development, both at a hormonal and 
neuroanatomical level. 
Early life stress is well documented as being a strong predictor for the development of 
psychiatric disorders, particularly anxiety and depressive disorders (Nugent et al., 2010, Enoch, 
2010). Bradley et al. (2008) demonstrated that individuals who have experienced childhood 
trauma scored significantly higher on Beck’s Depressive Index (BDI), and managed to use 
polymorphisms in the corticotropin-releasing hormone gene as predictors for higher BDI scores. 
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Given the intertwined development of SUD with ADs, ELS has a clear impact on the 
development of substance addiction later on in life. In a study conducted by al’Absi, Nakajima, 
and Lemieux, individuals who have experienced ELS were found to have more severe 
withdrawal symptoms in the form of reporting more pain after being exposed to a pain stimulus 
(2018). These findings suggest that the heightened level of anxiety of individuals that have 
experienced high levels of ELS in their lifetime have a strong influence on their anxiety. The 
relationship between drug addiction and anxiety can be defined as a distress-addiction cycle, 
meaning that the presence of a stressor can increase drug seeking behavior, thereby furthering 
drug exposure and addiction. Within the brain, this system is thought to be established by the 
interactions of the HPA axis and the mesolimbic system (Sinha, 2008). Operating under a 
distress-addiction cycle model of addiction provides a sensible explanation as to why ELS 
individuals are more susceptible to drug addiction. Their dysfunctional HPA axis established by 
a previous childhood trauma or neglect would result in increased CRF levels that could be 
alleviated by the use of a drug such as opioids or psychostimulants. Once the effects of the drug 
wear off and the individual is presented with an additional stressor, whether it be physical or 
psychosocial, the individual would likely experience comparable or higher CRF levels, pushing 
them to alleviate their symptoms again with the use of the same drug.  
Risk of Cocaine Addiction and ELS 
Neighborhood lower socioeconomic status correlates strongly with drug addiction rates in 
a population, suggesting that those with fewer resources and poor living conditions lead to a 
greater chance of cocaine addiction as well as physiological dysregulation that lead to an 
increase in allostatic load (Williams, 2007; Schroeder et al., 2001; Ribeiro et al., 2018). The 
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stress caused by growing up in these conditions can be simulated in rats by the various Early Life 
Stress models, one of which is Maternal Separation (MS) (Molet et al., 2014; Lewis et al. 2016). 
In this model of stress, rat pups are separated from their mother for a variable length of time, 
typically once a day for the first two weeks of life. Adult rats that have been subject to this model 
have shown an increase of anxiety-like behavior when placed in conditions such as the elevated 
plus maze (Wang et al., 2017). This model provides a seemingly stable level of anxiety into 
adulthood for rats that are subject to 180 minutes of separation for the first two weeks after birth. 
Murthy and Gould (2018) suggest that the MS model has a number of issues with uncontrollable 
variability, including the ability of the dam from each group to provide compensating attention to 
the pups after each separation. While this variation in care as a response to separation does have 
face-validity for humans as human mothers raising children in the same conditions can provide 
varying levels of care, it can make results from the rat model of MS more difficult to interpret. 
Addiction in Adolescence  
Adolescence presents a period of development during which an individual is considered 
to be at a much greater risk for being exposed to addictive substances and developing an 
addiction to these substances. Wong et al.’s study examining cocaine self-administration in 
adolescent rats revealed that adolescence does present a developmental stage in which cocaine 
addiction is acquired more easily and faster than during adulthood. Dopamine pathways in 
adolescent rats also demonstrated a higher level of activity, further implicating the high risk of 
adolescent cocaine use when compared to use during adulthood (Wong et al., 2013). As well as 
having a high risk of addiction, approximately 30% of adolescents suffer from one or more 
anxiety disorder (National Institute of Mental Health). This extremely high prevalence of anxiety 
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disorders and the strong comorbidity of SUD with ADs illuminate why adolescence is a 
reasonable target for anxiety and addiction studies. This becomes even more apparent when ELS 
is taken into consideration as a common cause for the development of a variety of anxiety 
disorders. There is a strong likelihood that the development of some form of anxiety disorder as 
the result of a childhood experiencing ELS could result in the development of some form of 
SUD. With the distress-addiction cycle in mind, it is possible that a heightened level of anxiety 
from an AD caused by ELS could enhance drug-seeking behavior due to a dysregulation in the 
HPA axis and the cascade of interactions that follow in the mesolimbic system. 
Cocaine Pharmacology 
Substances of abuse such as cocaine and morphine often result in a pattern of behavior 
known as behavioral sensitization. In rats, sensitization essentially has the opposite effect of 
tolerance and can be observed as an increase in locomotor activity with each subsequent 
administration of cocaine. This behavioral trend is considered to be one aspect of 
psychostimulant addiction development and has been shown to have lasting effects in rats long 
after the most recent exposure (Marin, 2008, Schoffelmeer, 2002). Psychostimulants such as 
cocaine and amphetamine are believed to mediate the increase of psychomotor activity through 
the intermittent increase of dopamine in the synaptic space in the medial prefrontal cortex 
(mPFC). This dopamine pathway begins at the Ventral Tegmental Area (VTA), which has been 
shown to be the area of the brain that interacts with psychostimulants. Activity in the mesolimbic 
pathway has demonstrated as having an influence on expressed anxiety. Some studies have 
demonstrated that stress appears to be induce the release of dopamine metabolites in the nucleus 
accumbens and the mPFC (Sorg and Kaivas, 1993). Habituation of psychostimulants is believed 
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to be mediated by the dorsal striatum. In the beginning uses of a drug such as cocaine, the VTA 
would send send an excess of DA to the NAc shell, and then later to the NAc core. At this point 
in habitual drug use, more DA is sent to the DS, and glutamatergic transmission within the DS 
has been implicated to be important in drug-induced adaptations (Taylor, 2013). While the 
nigrostriatal pathway also contain dopaminergic neurons, it is not believed to be involved in 
addiction acquisition, but rather in the locomotor expression of behavioral sensitization. This was 
demonstrated in a study conducted by Beeler et al., using ​Pitx3​-deficient mice, meaning the mice 
had no functioning nigrostriatal pathway (2008). The proposition that repeated exposure to stress 
induces increased dopamine metabolism provides further understanding to the current 
understanding of psychostimulant addiction and the way in which it interacts with ELS. 
However, more recent investigations of dopamine inhibitors, such as Monoamine Oxidase A 
(MAO-A), have found that acute psychosocial stressors result in a decrease in MAO-A binding 
in human brain (Soliman et al., 2012). Conflicting implications of MAO-A production during 
stress complicates the role of dopamine in the mesocortical pathway as it relates to stress, and 
thereby mystifies the direct connection between stress and psychostimulant addiction.  
ELS in Rats 
Animal models of ELS and addiction have furthered our understanding of the relationship 
between the two behavioral factors. Rats with that have experienced maternal separation for 180 
minutes each day of their first two weeks of life managed to acquire cocaine-self administration 
at a low test dose whereas groups of rats that received “maternal handling” (15 minutes of 
separation with handling) did not (Moffet et al., 2007). The same study also confirmed that the 
lower dosage threshold for self administration was not a result of lower drug metabolism by 
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measuring the levels of liver carboxylesterase, which did not differ between the MS group and 
the control group. Varghese et al. sought to explore this idea when they developed their own 
model of ELS by developing a mouse model where CRF was overexpressed, and then measuring 
their morphine sensitization and withdrawal symptoms when compared to wild  type (2015). 
Although this study may not have the same proportional level of CRF that would be present in 
rats that experienced ELS similar to the MS model, it does prevent a lot of the unpredictability 
involved with the variations in maternal rearing as a response to separation. After overexpressing 
CRF in mice, Varghese et al. determined that the synthetic ELS mice experienced significantly 
higher morphine sensitization and withdrawal symptoms. Using a mouse model specifically 
altered to produce an increase in CRF helps to confirm what was determined in previous studies 
on humans while also establishing a relationship between the HPA axis and drug-addiction 
behavior.  Research conducted by Hynes et al. revealed that rats who were exposed to a number 
of different forms of early life adversity immediately after weaning (predator odor, restraint 
stress, forced swim), were more sensitive to reward cues even without exposure to an addictive 
substance (2017). The determination that rats were more sensitive to a non-addictive reward cue 
demonstrates the powerful baseline influence early life adversity can have on an animal. If the 
non-addictive reward cue were to be replaced with a psychostimulant such as amphetamine or 
cocaine, which directly impact the reward pathway by blocking dopamine transporter, the 
increase of reward sensitivity would likely be even more pronounced. The heightened baseline 
reward sensitivity in rats that have experienced adversity is also useful to understanding the 
Distress-Addiction cycle, as it provides a glimpse into the incentives behind taking the drug for 
an ELS individual. Prior to drug exposure, if an ELS individual was already sensitive to rewards, 
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the euphoric rush of abusing a drug such as cocaine would be even greater than an average 
person. This experience, in tandem with the already heightened baseline of CRF that makes the 
highs seem higher and the lows seem lower, would create a self-perpetuating cycle of abuse. 
Anxiety-like Behavior Assays in Rats 
The elevated plus-maze (EPM) is a commonly used behavioral assessment of anxiety-like 
behavior in rats. EPM tests allow researchers to observe the anxiolytic or anxiogenic effects of a 
variety of stressors and pharmacological intervention, while maintaining face validity by taking 
advantage of rats’ natural fear of heights and open spaces (Walf and Frye, 2007). A study 
assessing the anxiety-like behavior in adolescent rats after MS took advantage of the EPM to 
measure anxiety-like behavior (Jin et al., 2018). This particular study only recorded two 
behaviors from the EPM, those being the number of entries in the open arm and the time spent in 
the open arm. The adolescent rats exposed to maternal separation showed significantly fewer 
open arm entries and significantly less time in the open arm, indicating a heightened level of 
anxiety. Demonstrating a heightened level of anxiety using EPM not only demonstrates the 
usefulness and validity of EPM as a behavioral assessment, but also provides further evidence 
that MS can produce anxiety during adolescence.  
Another common method of measuring anxiety-like behavior is the open field test (OF). 
Although OF has been used by since the 1930s to measure “emotionality” in rodents, the actual 
interpretation of results and how they can relate to emotional states such as anxiety in rodents is 
a subject of intense debate (Seibenhener and Wooten, 2015). Rather than taking advantage of 
two innate fears like in the EPM, OF testing is a measure of locomotor activity, where the total 
distance traveled is measured in some capacity. In addition to locomotor activity, “zones” can be 
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artificially constructed (such as the edge and center of the open field) to help interpret 
anxiety-like behavior. Anxiogenic behavior is typically thought to be an increase in the amount 
of time spend in “edge” zones. The reason for this follows the natural fear of open areas that is 
also used in the EPM. Jin et al. also used the OF in their analysis of anxiety-like behavior in 
adolescent rats. The adolescent rats raised with MS conditions were found to cross significantly 
more of the lines that divided the open field, while simultaneously making fewer entrances into 
the “central” zone (Jin et al., 2018). This provides a clear demonstration of the difficulties in 
interpreting locomotor activity as it relates to anxiety. While the MS rats crossed significantly 
showed significantly more locomotor activity, they also demonstrated a reluctance to enter the 
central zone of the open field test. Although it was not explicitly stated in Jin et al.’s results, it is 
most likely that the majority of locomotor activity was expressed outside of the central zone, 
which would follow the logic of more anxious rats being less likely to overcome the fear of open 
spaces. 
The purpose of this study is to examine how the the relationship between MS and cocaine 
addiction affect expressed levels of anxiety in adolescent rats. While ELS and cocaine addiction 
are two well-documented fields of research, their combinatory influence on expressed levels of 
anxiety has yet to be thoroughly explored. This presents an issue when attempting to assess 
treatment strategies for an individual who has both experienced ELS and developed an addiction 
to cocaine. It is possible that the combination of both of these psychosocial stressors could have 
a cumulative effect and result in a much higher risk of relapse. Without a proper understanding 
of how the combination of these two stressors interact, individuals attempting to recover from a 
cocaine addiction may not receive the most appropriate form of treatment to increase their 
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likelihood of success. In order to quantify anxiety like behavior in this study, the elevated plus 
maze and open field tests will be used at various stages of the rats’ cocaine or saline treatment. 
The behavioral trends elucidated by this study have the potential to lead to research surrounding 
the specific biomarkers that contribute to the increasingly anxious behavior with the addition of 
each additional stressor.  
Methods 
Research Design 
This experiment is a true experimental design. The two independent variables 
investigated in this study are exposure to Maternal Separation and exposure to cocaine. Maternal 
separation has two levels (separated and not separated), and cocaine exposure had three levels (0 
mg/kg, 10 mg/kg, and 20 mg/kg). The dependent variables for this study based on EPM testing 
consisted of open arm entries, open arm time (seconds), closed arm entries, protected head dips, 
unprotected head dips, end-of-arm head dips, and stretch attend. The dependent variables based 
on Open Field testing consisted of number of squares crossed, and time spent at the edge 
(seconds).  
Subjects 
With the use of the Maternal Separation model of Early Life Stress, it was necessary to 
use 66 Sprague-Dawley rats born from 6 different dams under the supervision of Connecticut 
College’s Animal Care Facility. Newborn pups were raised by their respective dam until they 
became old enough to be weaned. All animals had ad libitum access to food and water and were 
housed under standard conditions on a 12 hour on 12 hour off light-dark cycle.  One rat died due 
to a complication during a cocaine injection. 
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Materials 
The elevated plus maze is an apparatus used to analyze anxiogenic compounds as well as 
for anxiety research in general. The EPM consists of a “plus” shaped structure which includes 
two closed arms surrounded by walls and two open arms which have no arms around them. The 
arms are elevated 50 cm above the floor.  This model is used due to research that shows rats’ 
aversion to open spaces, and a tendency to remain in the closed arms, as this is a safer space for 
the animals (Roy et. al, 2009). 
The open field is another apparatus used to analyze anxiety-like behavior in mice. The 
open field apparatus used in this experiment was 2 meters x 2 meters surrounded by a 50 cm 
wall, and segmented into 20 cm squares with a 5 cm “edge area” extending from each wall. The 
same aversion of open spaces that applies to the elevated plus maze applies to the open field test, 
with the “edge area” taking the place of the closed arms as the safer space for the animal to stay. 
Cocaine hydrochloride (Sigma-Aldrich) was administered to rats via intraperitoneal 
injections. The cocaine was dissolved in sterile saline at a concentration of 10 mg/mL or a 20 
mg/mL. Rats in the non-cocaine groups were administered an equivalent volume of sterile saline. 
  Following testing, each rat was euthanized via carbon dioxide exposure as specified by 
the approved ACUP procedure. 
Procedure 
Timed-pregnant dams were received at approximately 18 days after conceiving.  After 
each dam was received, their cages were monitored daily for the birth of pups. The day that the 
pups were born was indicated as Postnatal Day 1 (PND1). Before the pups were born, and 
throughout the time in which the pups were house with the mother, food and water were 
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available ad libitum. After the pups were weaned on PND21, they were each housed in groups of 
three or four with their respective littermates. 
Maternal Separation 
Starting on PND2, the dams of the three Maternal Separation (MS) groups were housed 
in a separate cage with access to food and water for a period of 180 minutes, after which the dam 
was returned to her pups. MS was performed on a daily basis through PND15. 
Cocaine injections 
Cocaine was dissolved in a saline solution at a concentration of 10 mg/mL and 20 
mg/mL. Starting approximately PND28, the rats were weighed and administered their designated 
dose and appropriate volume of cocaine solution to deliver a 10 mg/kg or a 20 mg/kg dose. All 
cocaine injections were delivered into the intraperitoneal cavity. In order to mitigate the 
difference in stressors experienced by each group of rats, the groups that were not designated to 
receive cocaine were administered an equivalent volume of saline solution. After all injections 
that were not followed by locomotor activity monitoring, all rats were placed back into their cage 
with their the same litter mates they had been housed with previously.  
Behavioral Sensitization 
All rats were subject to locomotor activity testing on their first, seventh and fourteenth 
day of injection (approximately PND28, PND35, PND42). Locomotor activity was measured by 
placing injected rats into a standard cage placed inside an activity monitor frame.. Each time the 
rat moved and interrupted an infrared beam, a counter on the photocell monitor would increase 
by one. Cages in the photocell monitors were equipped with a minimal amount of bedding in an 
attempt to not cause any additional stress on the tested rats by putting them in an unfamiliar 
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setting, while also ensuring that the bedding did not interfere with the photocell monitor’s ability 
to present accurate data. The testing period lasted for 30 minutes, after which the number shown 
by the photocell monitor was recorded and the rats were returned back to their cages. 
Cocaine Extinction 
After the fourteenth injection of cocaine, the rats were then put through a 14 day 
extinction period, during which food and water were still available ​ad libitum​.  
Open Field Testing 
In order to assess expressed anxiety-like behavior, each rat was monitored in the open 
field at three separate timpoints:  the day before cocaine injections started (Baseline), after 
injections were complete (Post-Inj), the last day of cocaine extinction (Post-Extinction). These 
OF testing days were planned to take place approximately on PND26, PND43, and PND55. 
During each trial, rats were allowed to explore the open field freely, and were scored on the 
amount of time they spent at the edge of the field (in seconds) and the number of squares they 
crossed in their 5 minute trial. 
Elevated Plus Maze Testing 
In order to assess their expressed anxiety-like behavior, each rat was monitored on the 
elevated plus maze on three separate occasions: baseline, after injections were complete 
(Post-Inj), and after their cocaine extinction had ended (Post-Extinction), for a period of 5 
minutes. These EPM testing says were planned to take place approximately on PND27, PND44, 
and PND56. During each trial, researchers recorded each rat’s movements on the maze using 
LifeCam. LifeCam allowed researchers to record open arm duration, open arm entry, closed arm 
entry, protected head dips, unprotected head dips, and stretch attend posture. Open arm duration 
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was defined as the period of time during which all four of the rat’s paws were in the open arms. 
Open and closed arm entry were noted when all four paws were placed in the open or closed 
arms, respectively. A protected head dip was noted as all four paws were in the closed arm or the 
center of the maze and their head dipped downwards. An unprotected head dip was defined as 
having all four paws on the open arm and the head dipped downwards. An end-of-arm head dip 
was when a rat dipped its head at the end of the open arms. Stretch attend posture was marked 
when the tested rats would keep their hind paws in one place while slowly moving forward with 
their front paws, resulting in their body “stretching”. 
Data Analysis 
Once all of the behavioral testing was complete, differences in behavior were analyzed 
using a two-way ANOVA, followed by a Tukey’s multiple comparison test to determine the 
interaction between all of the behaviors measured in the EPM and OF testing. The pattern of 
locomotor activity was also analyzed in order to determine if rats exposed to cocaine became 
behaviorally sensitized during their injection period.  
Ethical Issues 
Animal subjects were required for this experiment and were approved for use in this 
study by the Institutional Animal Care and Use Committee in accordance with the Animal 
Welfare Act and the Guide for the Care and Use of Laboratory Animals. 
Results 
1. Locomotor Activity 
None of the groups exposed to cocaine (Coc10/MS, Coc10/No MS, Coc20/MS, 
Coc20/No MS) expressed any significant increase in locomotor activity from the second 
Anxiety Like Behavior with MS and Coc           Handy 17 
injection to the third injection. Both of the saline groups saw no significant change in locomotor 
activity (See Fig. 2).  
2. Elevated Plus Maze and Open Field 
2.1 First Cohort 
Two-way ANOVA analysis (timepoint x group) revealed a significant main effect for the 
number of open arm entries (F​ 6, 126​ = 5.426, p = <0.0001) as well as a significant difference in 
both the time point  (F​ 2, 126 ​= 23.85, p<0.0001) and group variables (F​ 3, 126 ​= 15.68, p<0.0001). 
Tukey’s multiple variable comparisons testing revealed a no significant difference in open arm 
entries for the Coc10/MS group when Baseline, Post-Inj, and Post-Extinction timepoints were 
compared. Sal/MS showed a significant decrease in the open arm entries when Baseline is 
compared to the Post-Inj and Post-Extinction time points (Baseline: 6.86 ± 2.73 vs. Post-inj: 2.43 
± 1.62 vs. Post-Extinct: 2.857 ± 1.86, p<0.0001). The Coc10/No MS group showed a significant 
decrease in open arm entries between the post-injection measurement and the post-extinction 
measurement, as well as the baseline compared to the post-extinction measurement (Baseline: 
2.67 ± 1.11 vs. Post-inj: 2.13 ± 1.06 vs. Post-extinct: 0.67 ± 0.62, p<0.005 and p<0.01 
respectively). The Sal/No MS group showed no significant differences in the number of open 
arm entries made while on the EPM.  
Between groups Tukey post-hoc comparisons revealed that the Sal/MS group made 
significantly more open arm entries compared to the Coc10/MS group at baseline (Sal/MS:  6.86 
± 2.73 vs. Coc10/MS: 1.50 ± 2.73, p<0.0001). The Coc10/MS group and the Coc10/No MS 
groups had no significant difference in the number of open arm entries made during the baseline 
measurement. The Coc10/MS and the Sal/No MS group also had no significant difference of 
Anxiety Like Behavior with MS and Coc           Handy 18 
open arm entries during the baseline test. The Sal/MS group was revealed to have made 
significantly more open arm entries than Coc10/No MS (Sal/MS:  6.86 ± 2.73 vs. Coc10/No MS: 
2.67 ± 1.12, p<0.0001) When Sal/MS was compared to Sal/No MS, the Sal/MS group was 
revealed to have made significantly more open arm entries (Sal/MS:  6.86 ± 2.73 vs. Sal/No MS: 
3.17 ± 1.03, p<0.0001). The Coc10/No MS and Sal/No MS groups had no significant difference 
in open arm entries ar baseline. There was no significant differences between any groups at the 
post-injection stage of testing. After the post-extinction stage of testing the Coc10/MS and 
Sal/MS groups, as well as the Coc10/MS and COC10/No MS has no significant difference in the 
number of open arm entries made during the five minutes on the EPM. Coc10/MS and the 
Sal/No MS groups had no significant difference in the number of open arm entries made in the 
EPM after their 14 day extinction period. The Sal/MS group did however make significantly 
more entries compared to the Coc10/No MS group  (Sal/MS: 2.86 ± 1.86 vs. Coc/No MS: 0.67 ± 
0.62, p<0.005), and the Coc10/No MS group made significantly fewer entries than the Sal/No 
MS group (Coc10/No MS:  0.67 ± 0.62 vs. Sal/No MS: 3.17 ± 1.03, p<0.0001). The Sal/MS 
groups and Sal/No MS groups has no significant difference in the number of open arm entries 
made while on the EPM (See Fig. 3).  
Two-way ANOVA analysis (timepoint x group) revealed a significant main effect for the 
number of closed arm entries (F​ 6, 126​ = 3.088, p = <0.01) and a significant difference in both the 
time point  (F​ 2, 126 ​= 24.72, p<0.0001) and group variables (F​ 3, 126 ​= 12.48, p<0.0001). Tukey’s 
multiple comparisons testing within each of the groups revealed that the Coc10/MS group had 
significantly fewer closed arm entries at baseline compared to the post-extinction round of 
testing (Baseline: 2.92 ± 1.56 vs. Post-Extinct: 1.50 ± 0.52, p<0.0001). There were no significant 
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difference in the number of closed arm entries made between the baseline and post-injection tests 
for the Coc10/MS group, nor was there a difference when the post-injection trial was compared 
to the post-extinction test. The Sal/MS group had a significant decrease in the number of closed 
arm entries after the baseline trail when compared to both the post-injection and post-extinction 
trials (Baseline: 5.86 ± 1.95 vs. Post-inj: 2.86 ± 1.77 vs. Post-Extinct: 2.57 ± 1.27, both 
comparisons p<0.0001). The Coc10/No MS group showed significantly fewer closed arm entries 
after extinction when compared to the baseline and post-injection trials (Baseline: 3.13 ± 1.06 vs. 
Post-inj: 2.27 ± 0.96 vs. Post-Extinct: 1.07 ± 0.46, p<0.0001 and p<0.05 respectively). There was 
no significant difference in closed arm entries for the Coc10/No MS group when the baseline 
trial is compared to the post-injection trial. The Sal/No MS group only showed only a significant 
decrease in the number of closed arm entries from the baseline test to the post-injection test 
(Baseline: 4  ± 1.06 vs. Post-inj: 2.67 ± 1.67, p<0.05). Neither the closed arm entries observed 
during the baseline nor the post-injection EPM trials were significantly different than the closed 
arm entries observed in the post-extinction trial. 
Between group comparisons of observed closed arm entries revealed that the 
Coc10/MS group made significantly more closed arm entries at baseline when compared to the 
Sal/MS group (Coc10/MS:  2.92 ± 1.57 vs. Sal/MS: 5.87 ± 1.95, p<0.0001). Coc10/MS had no 
significant difference in closed arm entries at baseline when compared to both the Coc10/No MS 
group and the Sal/No MS groups individually. The Sal/MS made significantly more closed arm 
entries when compared to the Coc10/No MS group at baseline (Sal/MS: 5.86 ± 1.95 vs. 
Coc10/No MS: 3.13 ± 1.06, p<0.0001). Sal/MS also had significantly more closed arm entries 
than the Sal/No MS group during the baseline test (Sal/MS: 5.86 ± 1.95 vs. Sal/No MS: 4.00 ± 
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1.28, p<0.05). There were no significant between group comparisons in the the number of closed 
arm entries made during the post-injection trial. The post-extinction trial revealed no significant 
difference between the Coc10/MS group and both the Sal/MS group and the Coc10/No MS 
group. The Coc10/MS group did however present significantly fewer closed arm entries than the 
Sal/No MS group during the post-extinction timepoint (Coc10/MS: 1.5 ± 0.52 vs. Sal/No MS: 
3.41 ± 1.78, p<0.005). Sal/MS had significant differences in closed arm entries with neither the 
Coc10/No MS group nor the Sal/No MS after the extinction period. The Coc10/No MS group 
had significantly fewer closed arm entries than the Sal/No MS group after the extinction period 
(Coc10/No MS: 1.06 ± 0.46 vs. Sal/No MS: 3.41 ± 1.78, p<0.0001) (See Fig. 4). 
Two-way ANOVA analysis (timepoint x group) showed no significant main effect for the 
number of protected head dips (PHD) performed and a significant difference in both the time 
point  (F​ 2, 126 ​= 12.81, p<0.0001) and group variables (F​ 3, 126 ​= 3.29, p<0.0001). Tukey’s multiple 
comparisons testing within each group revealed a significant increase in PHD observations from 
the baseline test to the post-extinction test in the Coc10/MS group (Baseline: 3.17 ± 2.25 vs. 
Post-Extinct: 6.58 ± 3.45, p<0.01). Neither the baseline nor the final timepoints for the 
Coc10/MS group differed in the number of PHDs observed when compared to the post-injection 
test. The Sal/MS group showed a significant increase from baseline to post-injection (Baseline: 
2.57  ± 1.39 vs. Post-inj: 6.71 ± 3.10, p<0.05), but had no significant differences when baseline 
was compared to the post-extinction test and the post-injection test was compared to the 
post-extinction test. The Coc10/No MS group experiences no significant changes in the number 
of PHDs expressed throughout each of the three trials in the EPM. The Sal/No MS group had a 
significant increase in PHDs observed at baseline compared to both the post-injection time and 
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the post-extinction time (Baseline: 4  ± 1.65 vs. Post-inj: 7 ± 2.76 vs. Post-Extinct: 6.92 ± 3.29, 
p<0.05 for both comparisons). There was no significant difference in the number of PHDs 
observed from post-injection to post-extinction in the Sal/No MS group.  
Between group comparisons revealed no significant differences in PHDs observed 
between any of the groups at baseline. There was also no significant difference between any of 
the groups in the number of PHDs made during post-injection testing. The Coc10/MS and 
Sal/MS group had no significant difference in the number of PHDs observed after extinction. 
Coc10/MS did perform significantly more PHDs than the Sal/MS group after the extinction 
period (Coc10/MS: 6.58 ± 3.45 vs. Sal/MS: 3.53 ± 2.75, p<0.05). No significant differences in 
PHD expression were found between the Coc10/MS group and the Sal/No MS group during the 
post-extinction test. The Sal/MS group had no significant differences in PHDs after extinction 
with both the Coc10/No MS group and the Sal/No MS group. The Coc10/No MS made 
significantly fewer PHDs than the Sal/No MS group (Coc10/No MS: 3.53 ± 2.75 vs. Sal/No MS: 
6.92 ± 3.29, p<0.01) (See Fig. 5) (See Fig. 5). 
Two-way ANOVA analysis (timepoint x group) showed a significant main effect (F​ 6 , 126 
= 5.43, p<0.0001) for the number of unprotected head dips (UHD) performed and a significant 
difference in both the time point  (F​ 2, 126 ​= 21.76, p<0.0001) and group variables (F​ 3, 126 ​= 8.02, 
p<0.0001). Within group multiple comparisons testing revealed a significant decrease in the 
number of UHD’s made by the Coc10/MS group when the baseline test was compared to both 
post-injection and post-extinction tests (Baseline: 10.5  ± 3.60 vs. Post-inj: 4.75 ± 2.76 vs. 
Post-Extinct: 2.17 ± 1.95, p<0.0001 for both comparisons). The Coc10/MS experienced no 
significant change in UHDs from the post-injection time to the post-extinction. There was no 
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significant change in the number of UHDs performed by the Sal/MS group throughout their 
series of tests. The Coc10/No MS group experienced a significant decrease in UHDs from 
post-injection testing to post-extinction testing (Baseline: 5.47 ± 2.95 vs. Post-inj: 3.67 ± 2.80 vs. 
Post-Extinct: 1.27 ± 1.83, p<0.0005 and p<0.05 respectively), but there was no significant 
difference from baseline to post-injection. The Sal/No MS group experienced a decrease from 
baseline to post-injection (Baseline: 7.17 ± 2.29 vs. Post-inj: 4.33 ± 2.10, p<0.05), but 
experienced no significant change from baseline to post-extinction or post-injection to 
post-extinction. 
Between group comparisons revealed that Coc10/MS made significantly more UHDs at 
baseline than the Sal/MS group (Coc10/MS: 10.50 ± 3.61 vs. Sal/MS: 5.29 ± 2.81, p<0.001),; 
significantly more UHDs than the Coc10/No MS group at baseline (Coc10/MS: 10.50 ± 3.61 vs. 
Coc10/No MS: 5.47 ± 2.94, p<0.0001; and significantly more UHDs than the Sal/No MS group 
at baseline (Coc10/MS: 10.50 ± 3.61 vs. Sal/No MS: 7.17 ± 2.29, p<0.001). Sal/MS had 
significant differences with neither Sal/No MS nor Coc10/No MS at baseline. Coc10/No MS and 
Sal/No MS also did not differ significantly at baseline. There were no significant differences in 
UHDs between any of the groups during the post-injection EPM trials. After the extinction 
period, it was revealed that Coc10/MS did not differ significantly from both the Sal/MS group 
and the Cco10/MS group. Coc10/MS did however show significantly fewer UHD than the 
Sal/No MS group (Coc10/MS: 2.17 ± 1.94 vs. Sal/No MS: 6.67 ± 4.40, p<0.001). The Sal/MS 
group showed no significant difference in observed UHDs compared to both the Coc10/No MS 
groups and the Sal/No MS groups. The Coc10/No MS group expressed significantly fewer 
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UHDs than the Sal/No MS group (Coc10/No MS: 1.27 ± 1.83 vs. Sal/No MS: 6.67 ± 4.40, 
p<0.001) (See Fig. 6).  
Two-way ANOVA analysis (timepoint x group) showed no significant main effect for the 
number of end of arm head dips (EHD) performed, but did have a significant difference in both 
the time point  (F​ 2, 126 ​= 14.99, p<0.0001) and group variables (F​ 3, 126 ​= 6.65, p<0.0001). Within 
group multiple comparisons revealed that the Coc10/MS group expressed significantly less EHD 
after the baseline test (Baseline: 3.08  ± 1.38 vs. Post-inj: 1.33 ± 1.30 vs. Post-Extinct: 1.00 ± 
0.85, p<0.0001 for both comparisons), but no significant difference between the post-injection 
test to the post-extinction test. The Sal/MS group demonstrated a significant decrease from 
baseline to post-injection (Baseline: 2.71  ± 1.70 vs. Post-inj: 0.42 ±  0.53, p<0.01), but then 
experienced a slight increase from post-injection to post-extinction that resulted in insignificant 
comparisons of both post-injection to post extinction and baseline to post-extinction. The 
Coc10/No MS group had no significant differences in EHDs when baseline was compared to 
post-injection or post-injection was compared to post-extinction, but there was a significant 
decrease in the number of EHDs from baseline to final (Baseline: 1.80  ± 1.42 vs. 
Post-Extinction: 0.13 ± 0.35, p<0.005). There was also a significant decrease in EHD by the 
Sal/No MS group from baseline to post-injection (, followed by a slight increase from 
post-injection to post-extinction that resulted in an insignificant difference between 
post-injection and post-extinction as well as baseline and post-extinction. 
Between subjects comparisons revealed no significant difference in EHDs between any 
of the groups at baseline. Additionally, there were no significant differences in the number of 
EHDs expressed during the post-injection round of testing. There were also no significant 
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differences in expressed EHDs when Coc10/MS was compared to both Sal/MS and Coc/No MS 
during the post-extinction test. There was a significant difference between the Coc10/MS group 
and the Sal/No MS group (Coc10/MS: 1.00 ± 0.85 vs. Sal/No MS: 2.75 ± 2.83, p<0.05). Sal/MS 
showed no significant differences in the number of EHDs expressed during the post-extinction 
trial compared to both Coc10/No MS and Sal/No MS. After extinction Coc10/No MS did show 
significantly fewer EHDs than Sal/No MS (Coc10/No MS: 0.13 ± 0.35 vs. Sal/No MS: 2.75 ± 
2.83, p<0.0001) (See Fig. 7). 
Two-way ANOVA analysis (timepoint x group) showed a significant main effect for the 
number of stretch attend postures (SA) performed (F​ 6, 126 ​= 3.29, p<0.005), but did have a 
significant difference in both the time point  (F​ 2, 126 ​= 21.11, p<0.0001) and group variables (F​ 3, 
126 ​= 8.45, p<0.0001). Within subjects multiple comparisons revealed that rats in the Coc10/MS 
group demonstrated a significant increase in SA after the baseline test (Baseline: 1.00  ± 0.60 vs. 
Post-inj: 4.33 ± 1.72 vs. Post-Extinct: 4.58 ± 2.67, p<0.0001 for both comparisons), but had no 
significant difference between the post-injection and post-extinction tests. Rats in the Sal/MS 
group showed a significant increase in SA from baseline to post-extinction (Baseline: 0.86  ± 
0.90 vs. Post-Extinct: 3.57 ± 1.72, p<0.01), but showed no significant change from baseline to 
post-injection and from post-injection to post-extinction. Rats in the Coc10/MS group 
demonstrated a significant increase in SA from baseline to post-injection, and a significant 
decrease from post-injection to post-extinction (Baseline: 1.40 ± 1.24 vs. Post-inj: 3.67 ± 1.84 vs. 
Post-Extinct: 2.13 ± 1.78, p<0.001 and p<0.05 respectively). The significant decrease from 
post-injection to post-extinction resulted in an insignificant difference in the number of 
expressed SA between the the baseline and post-extinction of the final group. The rats in the 
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Sal/No MS group showed no significant change in expressed SA throughout their three different 
stages of EPM testing.  
Between group comparisons of SA revealed no significant difference in the number SA 
between any of the observed groups at the baseline test time. Coc10/ MS did not significantly 
differ from either the Sal/MS or Coc10/No MS groups in expressed SA, but did show 
significantly more SA than the Sal/No MS group of rats during post-injection testing 
(Coc10/MS: 4.33 ± 1.72 vs. Sal/No MS: 2.08 ± 1.83, p<0.01). Sal/MS demonstrated no 
significant difference in SA when compared to both Coc10/MS and Sal/No MS at baseline. 
Coc10/No MS also showed no significant difference in SA expression when compared to Sal/No 
MS. During the post-extinction tests, Coc10/MS showed no significant difference in SA 
performed when compared to Sal/MS, but did show a significantly more SA than the Coc10/No 
MS group (Coc10/MS: 4.58 ± 2.13 vs. Coc10/No MS: 2.13 ± 1.77, p = 0.001). Coc10/MS also 
demonstrated significantly more SA than Sal/No MS (Coc10/MS: 4.58 ± 2.13 vs. Sal/No MS: 
1.08 ± 0.79, p<0.0001). Sal/MS did not appear to significantly differ in SA posture compared to 
Coc10/No MS, but it did perform significantly more SA than Sal/No MS (Sal/MS: 3.57 ± 1.72 
vs. Sal No MS: 1.4 ± 1.24, p<0.01) during post-extinction testing. There was no significant 
difference in SA posture between Coc10/No MS and Sal/No MS during post-extinction testing 
(See Fig. 8). 
Two-way ANOVA analysis (timepoint x group) showed no significant main effect for the 
percent of time spent in the open (POA), but did have a significant difference in both the time 
point  (F​ 2, 126 ​= 29.18, p<0.0001) and group variables (F​ 3, 126 ​= 3.03, p<0.05). Within subjects 
comparisons revealed a significant decrease in POA from baseline to post-injection, and a 
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significant decrease in POA from baseline to final (Baseline: 30.47%  ± 10.55% vs. Post-inj: 
15.89% ± 12.85% vs. Post-Extinct: 8.58% ± 6.23%, p<0.005 and p<0.0001 respectively) in the 
Coc10/MS group. Coc10/MS did not have any significant change in POA from post-injection to 
post-extinction. The Sal/MS group also had a significant decrease in POA after baseline when 
compared to both post-injection and post-extinction (Baseline:32.76% ± 12.82% vs. Post-inj: 
13.57% ± 6.99% vs. Post-Extinct: 13.90% ± 11.10%, p<0.005 for both comparisons), but 
showed no significant change in POA from post-injection to post-extinction. Coc10/No MS also 
showed a significant decrease in the POA when baseline is compared to both the post-injection 
and post-extinction times (Baseline: 23.40%  ± 12.41% vs. Post-inj: 14.20% ± 9.21% vs. 
Post-Extinct: 6.87% ± 7.33%, p<0.05 and p<0.0001 respectively), but showed no significant 
change from post-injection to post-extinction. The Sal/No MS group had only a significant 
decrease in POA from baseline to post-injection testing (Baseline: 26.36% ± 8.21% vs. Post-inj: 
16.08%  ± 8.56%, p<0.0001), with no change in POA from baseline to post-extinction or from 
post-extinction from post-extinction. 
Between group comparisons revealed no significant differences in POA between any of 
the tested groups at both the baseline and post-injection time points. There was no significant 
difference in POA between Coc10/MS and Sal/MS, as well as a lack of difference between 
Coc10/MS and Coc10/No MS. There was, however, significantly lower POA during the 
post-extinction round of EPM testing in Coc10/MS when compared to Sal/No MS (Coc10/MS: 
8.58% ± 6.23% vs. Sal/No MS: 21.47% ± 12.92%, p<0.05). Sal/MS showed no significant 
difference in POA after extinction when compared to both Coc10/No MS and Sal/No MS. 
Coc10/No MS expresses a significantly lower POA when compared to Sal/No MS for the 
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post-extinction stage of testing (Coc10/No MS: 6.86% ± 7.32% vs. Sal/No MS: 21.47% ± 
12.92%, p<0.05) (See Fig. 9). 
Two-way ANOVA analysis (timepoint x group) showed a significant main effect for the 
percent of time in the open field spent at the edge (PAE) performed (F​ 6, 126 ​= 4.42, p<0.0005), 
and did have a significant difference in both the time point  (F​ 2, 126 ​= 20.92, p<0.0001) and group 
variables (F​ 3, 126 ​= 39.50, p<0.0001). Within group multiple comparison revealed that the 
Coc10/MS group demonstrated no significant change in PAE throughout the three different times 
of OF testing. The Sal/MS group showed no significant difference when the baseline test was 
compared to the post-injection test, but did have a significant increase in PAE after the end of 
their extinction period compared to both baseline and post-extinction (Baseline:40,24% ± 
26.55% vs. Post-inj: 35.00% ± 34.32% vs. Post-Extinct: 88.67% ± 8.62%, p<0.005 for both 
comparisons) Rats in the Coc10/No MS showed no significant difference in baseline PAE 
compared to post-injection PAE, but the baseline and post-injection measurements both were 
significantly lower than the PAE measured after extinction (Baseline:76.18% ± 14.16% vs. 
Post-inj: 75.73% ± 13.95% vs. Post-Extinct: 93.36% ± 10.28%, p<0.0001 for both comparisons). 
Sal/No MS showed no significant change in PAE throughout the course of open field testing.  
Between subjects comparisons revealed that Coc10/MS has a significantly higher PAE at 
baseline compared to Sal/MS (Coc10/MS: 90.81% ± 5.05% vs. Sal/MS: 40.24% ± 26.55%, 
p<0.0001). Coc10/Ms also expressed a significantly higher PAE than Coc10/No MS (Coc10/MS: 
90.81% ± 5.05% vs. Coc10/No MS: 76.18% ± 14.16%, p<0.05) at baseline. Coc/MS expressed 
no significant difference when compared to Sal/No MS at baseline. Sal/MS expressed 
significantly lower PAE than Coc10/No MS at baseline (Sal/MS: 40.24% ± 26.55% vs. 
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Coc10/No MS: 76.18% ± 14.16%, p<0.05), as well as significantly lower PAE than Sal/No MS 
at baseline (Sal/MS: 40.24% ± 26.55% vs. Sal/No MS: 90.61% ± 9.55%, p<0.0001). Coc10/No 
MS also had a significantly lower PAE at baseline than Sal/No MS (Coc10/No MS: 76.18% ± 
14.16% vs. Sal/No MS: 90.61% ± 9.55% , p<0.05). Immediately after the injection series had 
ended, the Coc10/MS group showed a significantly higher PAE than the Sal/MS group 
(Coc10/MS: 83.67% ± 8.40% vs. Sal/MS: 35.00% ± 34.31% , p<0.0001), but has no significant 
differences with both the Coc10/No MS and Sal/No MS groups. Sal/MS showed significantly 
lower PAE than the Coc10/No MS group (Sal/MS: 35.00% ± 34.31% vs. Coc10/No MS: 75.73% 
± 13.94% , p<0.0001), as well as a significantly lower PAE tha the Sal/No MS group (Sal/MS: 
35.00% ± 34.31% vs. Sal/No MS: 82.69% ± 12.38% , p<0.0001) during the post-injection 
testing. There was no significant difference between the PAEs of the Coc10/No MS and the 
Sal/No MS groups. There were no significant differences in PAE between any of the test groups 
for the post-extinction OF test time point (See Fig. 10). 
Two-way ANOVA analysis (timepoint x group) showed no significant main effect for the 
percent of time in number of squares crossed in the open field (SC), but did have a significant 
difference in both the time point  (F​ 2, 126 ​= 7.84, p<0.001) and group variables (F​ 3, 126 ​= 4.46, 
p<0.005). Within group multiple comparisons revealed no significant difference in the number of 
SC for the Coc10/MS group when baseline was compared to both post-injection and final, but 
there was a significant difference in SC when post-injection is compared to post-extinction 
(Post-inj: 43.83 ± 25.76 vs. Post-Extinct: 12.58 ± 13.29, p<0.05). Sal/MS expressed no 
significant change in SC throughout its three different trials in the OF. Coc10/No MS did not 
show any significant change in SC when baseline was compared to post-injection, but 
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post-extinction did show significantly lower SC than both baseline and post-injection 
(Baseline:44.87 ± 28.53 vs. Post-inj: 44.87 ± 28.53 vs. Post-Extinct: 14.33 ±  26.52 , p =0.01 for 
both comparisons). There was no significant change in SC for the Sal/No MS group throughout 
the three different time points in the OF testing.  
Between group multiple comparisons revealed that Coc/MS had significantly lower SC at 
baseline when compared to Sal/MS (Coc10/MS: 20.83 ± 16.28 vs. Sal/MS: 62.57 ± 37.13, 
p<0.05), but was not significantly different than both the Coc10/No MS groups and the Sal/No 
MS groups at baseline. Sal/MS did not express significantly different SC than the Coc10/No MS 
group, but did have significantly higher SC than the Sal/No MS group (Sal/MS: 62.57 ± 37.13 
vs. Sal/No MS: 20.41 ± 22.52 , p<0.05) at baseline. There was no significant difference in SC at 
baseline between the Coc10/No MS and Sal/No MS groups. Post-injection and post-extinction 
comparisons between groups revealed no significant differences.  
2.2 Second Cohort 
Two-way ANOVA analysis (timepoint x group) showed a significant main effect for the 
number of open arm entries performed (OAE)(F​ 6, 105 ​= 3.31, p=0.005), and did have a significant 
difference in both the time point  (F​ 2, 105 ​= 14.31, p<0.0001) and group variables (F​ 3, 105 ​= 11.77, 
p<0.0001). Within group multiple comparisons revealed that the Coc20/MS group experienced 
no significant changes in OAE throughout the three different testing times. The Coc20/No MS 
group showed no significant changes from baseline to post-injection and from post-injection to 
post-extinction, but did show a significant decrease in OAE from baseline to post-extinction 
(Baseline: 2.67 ± 1.95 vs. Post-Extinct: 1.07 ± 1.33, p<0.05). 
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Between group multiple comparisons revealed that the Coc20/MS group made 
significantly fewer OAE than the Sal/MS group (Coc20/MS: 2.60 ± 1.14 vs. Sal/MS: 6.86 ± 
2.73, p<0.0001), but did not significantly differ from the Coc20/No MS or Sal/No MS during the 
baseline stage of testing. Rats in the Sal/MS showed significantly more OAE than both the 
Coc20/No MS (Sal/MS: 6.86 ± 2.73 vs. Coc20/No MS: 2.67 ± 1.95, p<0.0001) and Sal/No MS 
groups  (Sal/MS: 6.86 ± 2.73 vs. Sal/No MS: 3.16 ± 1.03, p<0.0001) during baseline tests. The 
Coc20/No MS group and Sal/No MS groups did not significantly differ in the number of OAE 
observed at baseline. No significant differences in OAE were found between any of the tested 
groups during the post-injection stage of EPM testing. After the extinction period had ended, the 
Coc20/MS group was not found to have any significant differences in OAE compared to the 
Sal/MS, Coc20/No MS, and Sal/no MS groups. Rats in the Sal/MS groups also showed no 
significant differences in OAE compared to the Coc20/No MS and Sal/No MS during 
post-extinction testing. The Coc20/No MS group showed significantly fewer OAE than the 
Sal/No MS group (Coc20/No MS: 1.07 ± 1.34 vs. Sal/No MS: 2.75 ± 1.42, p<0.05) during the 
post-extinction stage of EPM testing (See Fig. 12).  
Two-way ANOVA analysis (timepoint x group) showed no significant main effect for the 
number of open arm entries performed (CAE), but did have a significant difference in both the 
time point  (F​ 2, 105 ​= 9.99, p=0.0001) and group variables (F​ 3, 105 ​= 7.91, p<0.0001). Within group 
multiple comparisons revealed no significant differences in expressed CAE between any of the 
testing times for the Coc20/MS group. Coc20/No MS also showed no significant change in 
expressed CAE throughout the three testing points 
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Between group testing revealed that the rats in the Coc20/MS group performed 
significantly fewer CAE than the Sal/MS group  (Coc20/MS: 2.60 ± 1.67 vs. Sal/MS: 5.87 ± 
1.95, p<0.005), but did not differ significantly from both the Coc20/No MS group and Sal/No 
MS group during the baseline test. Rats in the Sal/MS group performed significantly more CAE 
than the Coc20/No MS group (Sal/MS: 5.87 ± 1.95 vs. Coc20/MS: 2.80 ± 2.04 , p<0.0005), but 
showed no significant difference when compared to the Sal/No MS group at baseline. Coc20/No 
MS also showed no significant difference with the Sal/No MS group during baseline EPM 
testing. The post-injection round of testing revealed no significant differences in expressed CAE 
between any of the tested groups. Rats in the Coc20/MS group did not significantly differ in their 
expression of CAE from the Sal/MS, Coc20/NoMS, and Sal/No MS groups after the full 
extinction period. The Sal/MS group also did not significantly in CAE differ from both the 
Coc20/No MS group and the Sal/No MS group during post-extinction EPM testing. Coc20/No 
MS expressed significantly fewer CAE than the Sal/No MS group during post-extinction testing 
(Coc20/MS: 1.60 ± 0.91 vs. Sal/MS: 4.42 ± 1.78, p<0.005) (See Fig. 13).  
Two-way ANOVA analysis (timepoint x group) showed no significant main effect for the 
number of protected head dips performed (PHD), but did have a significant difference in both the 
time point  (F​ 2, 105 ​= 6.87, p<0.005) and group variables (F​ 3, 105 ​= 17.96, p<0.0001). Within group 
multiple comparisons revealed that the Coc20/MS group did not significantly change the number 
of PHDs expressed during each of the three testing times. The Coc20/No MS group showed an 
increase in the number of observed PHDs when the baseline test is compared to post-injection 
testing (Baseline: 1.40 ± 1.40 vs. Post-Injection: 3.6 ± 2.41, p<0.05). 
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Between group multiple comparisons revealed that the Coc20/MS group did not express a 
significantly different number of PHD compared to the Sal/MS, Coc20/No MS, and the Sal/No 
MS groups at the baseline stage of testing. Rats in the Sal/MS groups also performed no 
significant difference of PHDs when compared to both the Coc20/No MS and the Sal/No MS 
groups at baseline. Coc20/No MS, however, did show fewer PHDs when the compared to the 
Sal/No MS group at baseline. During the post-injection EPM testing, Coc20/MS showed 
significantly fewer PHDs than the Sal/MS (Coc20/MS: 1.80 ± 2.05 vs. Sal/MS: 6.71 ± 2.62, 
p<0.01) and Sal/No MS groups (Coc20/MS: 1.80 ± 2.05 vs. Sal/No MS: 7.00 ± 2.76, p<0.01), 
but did not significantly differ in PHD expression compared to the Coc20/No MS group at 
post-injection. Rats in the Sal/MS group performed significantly more PHDs than the Coc20/No 
MS group during post-injection testing (Sal/MS: 6.71 ± 2.62 vs. Coc20/No MS: 3.6 ± 2.41, 
p<0.05), but did not show a significantly different number of PHDs compared to the Sal/No MS 
group. Coc20/No MS showed no significant difference in PHD expression compared to the 
Sal/No MS group during post-injection EPM testing. After the extinction period a Coc20/MS 
showed a significantly lower number of PHD’s compared to the Sal/MS group (Coc20/MS: 1.00 
± 2.73 vs. Sal/MS: 5.42 ± 3.10, p<0.05) and the Sal/No MS group (Coc20/MS: 1.00 ± 2.73 vs. 
Sal/No MS: 6.92 ± 3.28, p=0.0001), but showed no significant difference with the Coc20/No MS 
group. The Sal/MS group showed no significant differences in PHDs performed with both the 
Coc20/No MS and the Sal/No MS groups during the post-extinction EPM tests. Rats in the 
Coc20/No MS group performed significantly fewer PHDs than the Sal/No MS group (Coc20/No 
MS: 2.73 ± 2.79 vs. Sal/No MS: 6.92 ± 3.28, p<0.0005) (See Fig. 14).  
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Two-way ANOVA analysis (timepoint x group) showed no significant main effect for the 
number of unprotected head dips performed (UHD), but did have a significant difference in both 
the time point  (F​ 2, 105 ​= 9.07, p<0.005) and group variables (F​ 3, 105 ​= 7.77, p<0.0001). Within 
group comparisons revealed that the Coc20/MS group expressed a significant decrease in UHDs 
after baseline, but did change significantly from post-injection to post-extinction (Baseline: 5.40 
± 2.95 vs. Post-inj: 3.67 ± 2.32 vs. Post-Extinct: 1.27 ± 1.84, p<0.05 for both comparisons). The 
Coc20/No MS expressed no significant difference of UHDs from baseline to post-injection and 
from post-injection to final, but did show a significant decrease from baseline to post-extinction 
(Baseline: 5.27  ± 3.15 vs. Post-Extinct: 2.26 ± 2.34, p<0.05).  
Between group comparisons revealed no significant differences in UHDs between any of 
the tested groups during baseline EPM trials. There were also no significant differences in 
observed UHDs between any of the tested groups during the post-injection EPM trials. 
Coc20/MS did not show a significantly different number of UHDs when compared to both the 
Sal/MS and Coc20/No MS groups, but did express significantly fewer UHDs than the Sal/No 
MS group  (Coc20/MS: 1.20 ± 2.27 vs. Sal/No MS: 6.67 ± 4.40, p<0.005). Sal/MS did not 
significantly differ in expressed UHD during the post-extinction EPM trial compared to both the 
Coc20/No MS and Sal/No MS groups. The Coc20/No MS group showed significantly fewer 
UHDs than the Sal/No MS group during the post-extinction test (Coc20/No MS: 2.67 ± 2.34 vs. 
Sal/No MS: 6.67 ± 4.40, p<0.001) (See Fig. 15).  
Two-way ANOVA analysis (timepoint x group) showed no significant main effect and no 
significant timepoint effect for the number of end of arm head dips performed (EHD), but did 
have a significant difference in both the and group variables (F​ 3, 105 ​= 5.58, p<0.005). Within 
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group multiple comparisons revealed that both the Coc20/MS and Coc20/No MS Groups did not 
significantly differ in performed EHDs throughout their various EPM trials.  
Between group multiple comparisons revealed that Coc20/MS did not significantly differ 
from the rats in the Sal/MS, Coc20/No MS, and the Sal/No MS groups in the number of EHDs 
observed during baseline. The Sal/MS group also demonstrated no significant differences with 
the Coc/No MS and the Sal/No MS when comparing the number of EHDs observed at baseline. 
The Coc20/No MS did, however, show a significantly lower number of EHDs than Sal/No MS at 
baseline (Coc20/No MS: 1.00 ± 1.25 vs. Sal/No MS: 3.00 ± 1.53, p<0.05). No significant 
differences in EHD expression were uncovered between any of the tested groups during the 
post-injection stage of testing. The Coc20/MS group did not significantly differ in EHD 
expression from either the Sal/MS or Coc20/No MS groups during post-extinction testing, but 
did show significantly fewer EHDs than the Sal/No MS group (Coc20/MS: 0.20 ± 1.2 vs. Sal/No 
MS: 2.76 ± 2.83, p<0.05). No significant difference in EHDs was observed when Sal/MS was 
compared to both the Coc20/No MS and Sal/No MS groups during post-extinction testing. The 
Coc20/No MS group also did not express a significantly different number of EHDs than the 
Sal/No MS group (See Fig. 16).  
Two-way ANOVA analysis (timepoint x group) showed no significant main effect for the 
number of stretch attend postures performed  (SA), but did have a significant difference in both 
the time point  (F​ 2, 105 ​= 7.17, p<0.005) and group variables (F​ 3, 105 ​= 4.22, p<0.01). Within group 
multiple comparisons revealed no significant change in SA performed by the Coc20/MS group 
between the baseline, post-injection, and post-extinction testing times. The Coc/No MS group 
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also showed no significant difference in the SA expressed between each of the three time point 
levels.  
Between group comparisons revealed that the number of SA performed in baseline tests 
did not significantly differ between any  of the tested groups. EPM testing at the post-injection 
level also showed no significant differences in SA between any of the tested groups. 
Post-extinction testing revealed no significant difference in performed SA between the 
Coc20/MS group and the Sal/MS, Sal/No MS, and Coc20/No MS groups. Sal/MS did show 
significantly more SA behavior than the Coc20/No MS group  (Sal/MS: 3.57 ± 2.67 vs. 
Coc20/No MS: 1.40 ± 1.24, p<0.01) during post-extinction EPM testing. No significant 
difference between the Coc20/No MS and Sal/No MS group could be found from the SA 
measured during post-extinction testing (See Fig. 17).  
Two-way ANOVA analysis (timepoint x group) showed no significant main effect 
percent of total time in the EPM spent in the open arm (POA) and no significant difference in the 
group variable, but did have a significant difference in the time point variable (F​ 2, 105 ​= 13.34, 
p<0.0001). Within group comparisons revealed that Coc20/MS POA significantly decreased 
from the baseline test to the post-injection test (Baseline: 43.26%  ± 36.02% vs. Post-inj: 13.73% 
± 16.40%, p<0.05), but saw no significant differences between baseline compared to 
post-extinction and post-injection compared to post-extinction. The Coc20/No MS group 
experienced a significant decrease in POA from baseline testing to post-injection testing 
(Baseline: 47.78%  ± 34.00% vs. Post-inj: 22.33% ± 25.08% vs. Post-extinct: 16.40% ± 18.48% , 
p<0.05), and then did not significantly change from post-injection testing to post-extinction 
testing.  
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Between groups multiple comparisons revealed that Coc20/MS did not show any 
significantly different POA from the Sal/MS, Coc20/No MS, and Sal/No MS groups at the 
baseline level. Sal/MS also did not significantly differ from Coc20/No MS at the baseline time 
point. Coc20/No MS had a significantly higher PAE than the Sal/No MS group during baseline 
testing (Coc20/No MS: 47.78% ± 34.00% vs. Sal/No MS: 26.36% ± 8,21%, p<0.05). No 
significant POA differences were found between any of the tested groups during the 
post-injection and post-extinction EPM time points (See Fig. 18). 
Two-way ANOVA analysis (timepoint x group) showed a significant main effect for the 
percent of total time spent in the open field spent at the edge (PAE)(F​ 6, 105 ​= 6.76, p<0.0001), and 
a significant difference in the group variable, but no significance in the time point variable (F​ 3, 105 
= 14.61, p<0.0001). Within group testing revealed a significant increase in PAE by the 
Coc20/MS group from baseline to post-extinction (Baseline: 52.07% ± 29.86% vs. Post-inj: 
93.93% ± 5.99% vs. Post-extinct: 88.67% ± 8.62% , p<0.005 and p<.05 respectively), followed 
by an insignificant decrease in the post-extinction trial. Rats in the Coc20/MS group showed no 
significant change in PAE from baseline to post-injection and from post-extinction, but revealed 
a significant decrease in PAE overall when baseline is compared to post-extinction (Baseline: 
82.76% ± 14.17% vs. Post-extinct: 59.98% ± 35.44% , p<0.01). 
Between group multiple comparisons revealed that Coc10/MS did not show significantly 
different PAE from Sal/MS at baseline, but Coc20/MS did express significantly less PAE than 
both Coc20/No MS (Coc20/MS: 52.07% ± 29.96% vs. Coc20/No MS: 82.76% ± 14.17%, 
p<0.05) and Sal/No MS at baseline (Coc20/MS: 52.07% ± 29.96% vs. Sal/No MS: 90.61% ± 
9.54%, p<0.005). Sal/MS showed a significantly lower PAE than Coc20/No MS at the baseline 
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level of testing (Sal/MS: 40.24% ± 26.55% vs. Coc20/No MS: 82.76% ± 14.17%, p<0.0001). 
Coc20/No MS did not significantly differ in measured PAE with the Sal/No MS group at 
baseline. The PAE measured at the post-injection time point for the Coc20/MS was significantly 
higher than Sal/MS (Coc20/MS: 93.93% ± 5.99% vs. Sal/MS: 35.00% ± 34.32%, p<0.005) , but 
did not significantly differ from either the Coc20/No MS group or the Sal/No MS group. Sal/MS 
significantly differed from Coc20/No MS at the post-injection time point (Sal/MS: 35.00% ± 
34.32% vs. Coc20/No MS: 70.46% ± 12.37%). The Coc20/No MS group did not express a 
significantly different PAE from the Sal/No MS at the post-injection time point. After rats in the 
test groups experienced their extinction, the PAE of Coc20/MS was determined to be 
insignificantly different from both Sal/MS and Sal/No MS, but was significantly higher than the 
Coc20/No MS group(Coc20/MS: 86.67% ± 8.62% vs. Coc20/No MS: 59.98% ± 35.44%, 
p<0.05). Sal/MS was observed expressing a PAE that was insignificantly different that that of 
Coc20/No MS after extinction. Coc20/No MS had a significantly higher PAE than Sal/No MS 
after extinction(Coc20/No MS: 59.98% ± 35.44% vs. Sal/No MS: 24.75% ± 22.52% , p<0.005) 
(See Fig. 19).  
Two-way ANOVA analysis (timepoint x group) showed no significant main effect and no 
significant timepoint effect for the number of squares crossed in the open field (SC), but did have 
a significant difference in both the and group variables (F​ 3, 105 ​=6.65 , p<0.0005). Within group 
comparisons revealed no significant differences for any of the tested groups between any of the 
different time points. Between group comparisons showed Coc20/MS showed insignificantly 
different SC from Sal/MS, Coc20/No MS and Sal/No MS for the baseline time point. Sal/MS 
showed significantly greater SC (Sal/MS: 62.57 ± 37.13 vs. Coc20/No MS: 17.4 ± 13.99, 
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p<0.005) at the baseline testing time. Analysis of post-injection SC revealed that Coc20/MS 
performed significantly fewer SC than the Sal/MS group (Coc20/MS: 11.00 ± 9.70 vs. Sal/MS: 
57.42 ± 36.66, p<0.05). Sal/MS performed significantly more SC than the Coc20/No MS group 
during the post-injection OF testing time (Sal/MS: 57.42 ± 36.66 vs. Coc20/No MS: 30.47 ± 
28.09, p<0.05). No significant differences in SC could be found between any of the groups after 
the extinction period (See Fig. 20). 
Discussion 
Assessment Maternal Separation 
While MS is a commonly used model of early life stress and has been implemented in 
numerous anxiety studies, in the current study model produced varying levels of baseline 
anxiety. This is indicated most clearly by the observed differences between all of the MS and No 
MS groups at the baseline measurement time. At this stage of testing, none of the rats had been 
exposed to any additional stressors other than maternal separation, and ideally that would 
indicate that the only differences in behavioral measurements would be between groups that have 
and have not experienced MS during their upbringing. With this in mind, the behavioral data 
presented in this study clearly demonstrates a difficulty in establishing a heightened level of 
baseline anxiety using MS. 
The low success of maternal separation in both the first and second testing cohorts is best 
indicated by the group differences at baseline in the UHD, SA, POA, and SC behavioral 
measures. Previous studies examining the effects of early life stress on anxiety in rats, as 
measured by the elevated plus maze and open field test, indicate that rats experiencing MS are 
less likely to explore the open arms of the EPM and more likely to cross squares in the OF (Jin et 
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al., 2018). Unprotected head dips are an accurate and easily interpreted measure of open arm 
exploration because they not only require that the observed rat is out on the open arm, but also 
require the rat to explicitly exploring the open arm environment by dipping its head below the 
horizontal plane of the open arm. With this in mind, there would be an expectation that the 
groups that have experienced MS would show fewer UHD than those who have not. This, 
however, was not the case in this experiment, as all of the significant measured UHD differences 
were the result of the Coc10/MS group indicating an unusually high mean UHD, which indicates 
a very low level of anxiety. The mean UHD was so high that it was significantly different than 
the Sal/MS group as well as the two groups in the first cohort that did not experience MS. There 
were no other differences in UHD between groups that did and did not experience MS during 
pre-weanling, which firmly puts forth the conclusion that the model of MS in this experiment 
was not successful in establishing basal levels of anxiety. 
Stretch attend posture is typically thought to be a measurement of anxiety that differs 
from behaviors based in open arm because it is considered to be a risk assessment behavior 
(Albrechet-Souza et al., 2007). Higher levels of observed risk assessment behaviors such as 
stretch attend indicate a higher level of anxiety, and inversely of UHD, a higher level of SA is 
expected of rats that had experienced MS in their upbringing compared to group that had not at 
the baseline EPM measurement. The complete lack of group differences for both cohorts at the 
baseline EPM test time indicates that MS was not successful in establishing an expressed level of 
heightened anxiety during the adolescence of the MS groups. 
 The percent of total time spent in the open arm is one of the most straightforward and 
reliable behavioral measures of anxiety that can be measured on the EPM. Much like the UHD, 
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time in the open arm is based on the premise that a rat experiencing more anxiety is less likely to 
act upon their normal exploratory behavior, and thus well spend less time in the open arm 
overall. The data collected in this experiment did not indicate any baseline measurements of 
POA where an MS group spent significantly less time in the open arm than a non-MS group. Due 
to the reliability and low interpretive margin of error in POA, the possibility of an unsuccessful 
MS becomes even more likely. 
 The number of squares crossed during the open field test is the last behavior commonly 
associated with anxiety in rats that cohesively establishes a failed maternal separation procedure. 
A study run by Jin et al. explicitly examined the relationship between rats experiencing maternal 
separation during their upbringing and the behavioral measures that result from that experience. 
Jin et al.’s study determined that adolescent rats who have been exposed to maternal separation 
demonstrated significantly higher levels of locomotor activity in an open field test. The manner 
in which Jin et al. measured locomotor activity differed from this study in that it measured the 
number of lines crossed at both the edge and in the central zone, making no distinction between 
the two. With this in mind, the method of measuring locomotor activity has a low validity 
without a corresponding PAE measurement to support it.  The baseline measure in this 
experiment indicated there was only comparative instance where an MS group crossed 
significantly more squares than a non-MS group. Inconsistent data such as the MS to non-MS 
comparison in the number of squares cross during the OF is indicative of the failure of the model 
of MS used in this experiment to heighten the baseline levels of anxiety in adolescent rats.  
Without the establishment of a heightened expression of anxiety-like behavior during baseline 
measurements for rats that have experienced maternal separation, it becomes important to 
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consider the possibility that any endocrinological changes spurred by MS could be expressed 
later in adolescence, such as at the post-extinction timepoint. When the same behaviors 
examined at the baseline time point are explored, this possibility begins to fall short. There was 
no significant differences between any corresponding MS to non-MS groups, lowering the 
possibility of a later onset of anxiety-like behavior. Both POA and SC present the same pattern 
expression in each of their respective tests at the post-extinction time point, which works 
strongly against the possibility of late behavioral onset.  The measurement of stretch attend 
posture during the post-extinction time period presents the best argument for a late onset because 
there are two pairs of directly corresponding MS to non-MS groups that significantly differ with 
the MS groups presenting significantly higher numbers of SA. This behavior alone, however, 
does not present a convincing argument in favor of an expression of behaviors later in 
adolescence and appears to be more of an artifact than anything else. 
 One design aspect of the typical MS model used in early life stress studies that could 
have been overlooked during this study was the thermoregulation of the pups during the 
separation. The vast majority of studies examining maternal separation that have shown some 
significant difference in behavior compared to pups that experienced normal rearing conditions 
were sure to keep the pups body temperature at a temperature similar to that of the mother 
(around thirty degrees celsius), but no such thermoregulatory measures were taken in the design 
of this study. It has been proposed that the mechanisms controlling upregulation of 
cortico-releasing hormone can be significantly impacted by the presence of a cold-stressor in 
neonatal rats, but that these mechanisms may be immature during the first postnatal week (Yi 
and Baram, 1994). This theory could provide an explanation for the lack of consistent anxiety 
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like behavior expressed by the MS groups of this study. Without an immature mechanism to 
upregulate CRH due to the cold temperatures from PND 2-7, it is possible that CRH was not 
elevated appropriately, and therefore the HPA axis would stay relatively unaffected throughout 
the entire separation period. If this were to be the case, the rats would likely behave in a very 
similar way to the groups that never experiences separation because they both have unaffected 
HPA axes. Dysregulation of the HPA axis during the neonatal period is one of the hallmark 
components of early life stress, and there is not like to be any real change in behavior without 
such a change. 
The lack of an apparent stress response induced by MS could have been the result of dam 
response to the separation period. The level of dam attentiveness was not monitored or measured 
in this study, but a heightened level of maternal care immediately following separation has been 
shown to significantly reduce the stress response of mice later on in life (Own and Patel, 2013). 
A variable such as this could be another confounding variable of this study that demonstrates the 
flexibility and complicated nature of stress and anxiety as it presents itself in animal models. 
Uncontrollable variables such as the mother’s response to a separation period is likely one of the 
primary reason MS struggles with producing consistent stress responses in rats and as result, 
complicating results produced by studies examining ELS.  
Another major limitation in this study was the need to limit the size of a group to the 
number of pups born into a litter. In order to ensure that the pups were raised in the appropriate 
maternal care conditions, it was necessary to keep each of the pups in the litter that they were 
born into. The result of this design was substantial variability between each of the groups, the 
smallest group having only 5 subjects, and the largest having 15. Groups as small as 5 rats did 
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not provide an appropriate sample size to produce reliable results within each of the testing 
conditions. Additionally, the groups in this study most affected by a small sample size were all 
groups designated to experience MS, which tends to have variable results even without further 
complications. Smaller groups could have also could have become more resilient to MS because 
the competition for maternal care was so much lower. Even if there were methodological errors 
in the design of this studies MS model, smaller groups as Sal/MS (n=7) and Coc20/MS (n=5) 
could have had a reduced MS affect because the dams of each group were able to provide more 
attention than the other groups with 12 or more pups. 
Assessment of Behavioral Sensitization 
The lack of  a consistent increase in the locomotor activity measured from the first 
injection to the seventh injection, to the fourteenth injection indicates that none of the rats 
exposed to cocaine (Coc10 and Coc20 groups) were sensitized by the end of their injection cycle. 
Both groups showed significantly higher means of locomotor activity than the saline groups, but 
the lack of locomotor activity patterns consistent with those seen in previous studies examining 
behavioral sensitization during adolescence (Elwenspoek et al., 2017) suggests that the rats were 
missing a hallmark trait of cocaine addiction. The lack of sensitization in the Coc10 groups was 
originally thought to be attributed to the 10 mg/kg daily dose of cocaine being too low of a dose 
to induce sensitization as indicated by various studies that injected 10 mg/kg up to three times 
per day to induce sensitization. This low dosage theory, however, was disproven by the lack of 
sensitization in the Coc20 groups. A study conducted by Garcia-Rubio et al. suggests that the 
maternal separation that the rats experiences can reduce the level of locomotor activity expressed 
by adolescent mice (2016). There would be a possibility the phenomena demonstrated in 
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Garcia-Rubio’s experiment could explain the lack of sensitization in rats exposed to cocaine if 
not for the fact that both MS and No MS rats exposed to cocaine experienced the same decrease 
in locomotor activity from the seventh injection to the fourteenth injection. 
If this stage of the experiment was to be altered, a binge-pattern of injections would likely 
produce a more reliable sensitization. The binge-pattern of injections requires that three doses of 
cocaine be delivered an hour apart shortly after the light portion of the 12h light/dark cycle 
begins. Establishing behavioral sensitization reliably would have made afforded this study more 
conclusive results and concrete data analysis.  
Another complication of this study that could have affected behavioral sensitization, 
could be the environmental differences between locomotor activity testing days and normal 
injection days. Rats in this study were placed back into their respective home cages after every 
injection other than the days their locomotor activity was monitored. Testing chambers for 
locomotor activity present an extremely different environment than their home cage (isolation, 
less bedding), which likely affected their expression of locomotor activity. There is not a lot of 
empirical evidence to support this idea because the vast majority of behavioral sensitization 
studies measure locomotor activity on a daily basis. In an ideal situation, locomotor activity 
would have been monitored on a daily basis, but due to the limitations of an undergraduate 
schedule, this was not possible.  
Assessment of Cocaine-Induced Anxiety 
Cocaine has been documented in numerous studies to have prominent influences on the 
expression of anxiety-like behavior during adolescence, particularly when a period of abstinence 
is introduced (Valzachi et al., 2013 and El Hage et al., 2012). EPM data from this study indicates 
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that this trend held true for many of the different groups receiving cocaine injections even though 
there was no strong behavioral sensitization established. Within group comparisons best illustrate 
the increase in anxiety-like behavior due to cocaine, which can then be compared to saline 
groups in the post-injection and post-extinction time points to confirm both that there was a 
significant change in anxiety from baseline and that the change is likely due to cocaine exposure. 
A consistent pattern of increased anxiety-like behavior within cocaine groups is shown by 
the measurement of UHD, which has previously been established as a reliable measure of 
anxiety like activity. All groups exposed to cocaine (Coc10/MS, Coc10/No MS, Coc20/MS, 
Coc20/No MS) all expressed a some significant decrease in UHD after baseline, suggesting an 
increase in anxiety like behavior. In the case of the of the Coc10/MS and Coc20/MS groups, 
there was a significant decrease from baseline to post-injection, but no significant change after 
that. This shared pattern of UHD expression indicates that MS could possibly have some sort of 
influence on anxiety-like behavior after extinction, which is supported by the pattern of UHD 
expressed by the Coc10/No MS. The Coc10/MS group expressed no significant decrease in UHD 
after baseline, but did demonstrate a significant decrease from post-injection to post-extinction. 
This could indicate that MS blocks some of the additional stress normally caused by an 
abstinence from cocaine, but this is of course made less clear by both the lack of a similar pattern 
in the Coc20/No MS group and by the low level of successful MS that has already been 
established. Although the influence separation has is unclear, groups exposed to only the cocaine 
stressor (Coc10/No MS and Coc20/No MS) expressed significantly fewer UHD a the 
post-extinction EPM testing time compared to their direct saline counterparts. This is a very clear 
indication that the rats exposed to both the low and the high dose of cocaine were more anxious 
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after a period of abstinence, supporting the findings of previous research to suggest cocaine 
exposure followed by abstinence has a prominent anxiogenic effect.  
Protected head dips also offer some insight into the anxiogenic effects of cocaine 
exposure and abstinence by demonstrating some of the same comparisons as UHD. PHD can be 
interpreted in a similar manner as stretch attend posture, that is to say an increase in PHD 
indicates an increase in anxiety as it is a risk assessment behavior as opposed to an exploratory 
behavior. The only two cocaine groups that demonstrated a significant increase in PHD after 
baseline were Coc10/MS and Coc20/No MS. Coc10/MS decreased the number of expressed 
from baseline to final, which is consistent with the pattern of expression in UHD, but Coc20/MS 
only demonstrated a significant increase in PHD from baseline to post-injection. Many of 
cocaine exposed groups demonstrated significant differences from their direct saline 
counterparts, but with only a significant increase from baseline in the Coc10/MS and Coc20/MS, 
not many of these significant differences can be attributed solely to cocaine and cocaine 
abstinence.  
Another behavior that provided a seemingly reliable depiction of cocaine’s effect on 
expressed anxiety was POA. Every tested group in both cohorts demonstrated a significant 
decrease in the POA, suggesting that there was a shared increase in anxiety across all 
experimental conditions. When groups are compared after extinction, however, both of the 
Coc10 groups spent significantly less time in the open arm when compared to their saline 
counterparts, indicating that the lower dose of cocaine resulted in a significant effect whereas the 
higher dose did not.  
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Confirming the effect of cocaine and the following period of abstinence becomes more 
difficult when lack of behavioral sensitization is taken into consideration. Exposure to cocaine 
and the related abstinence period does seem correlate with the expressed anxiety in some 
behaviors, but this cannot be determined to be a result of cocaine sensitization due to a lack of 
sensitization behavior. Anxiety has been well characterized as a symptom of initial cocaine 
addiction (Sarnyai et al.m 1995), which does suggest that although the rats in this study did not 
express behavioral sensitization patterns of locomotor activity, they may be experiencing some 
anxiety related drug-related behavior such as craving. A useful behavioral measurement that 
could have helped mitigate the impact of such an error would be stereotypy scoring of each rat 
during each locomotor activity monitoring periods.  
Conclusion 
This study was limited primarily by scheduling conflicts that come with a full time 
undergraduate schedule. While it would have been ideal to expose rats to cocaine using the binge 
pattern of injections and to monitor they stereotypy of each rat during the locomotor activity 
monitoring, these designs were made nearly impossible by the time constraints. One aspect of 
anxiety that this study does suggest is the incredible resilience of organisms to endure and 
overcome stress throughout their lifetime. The half of the rats exposed to MS in this study not 
only had to endure the stress of an ELS model, but also the exposure to an incredibly addictive 
substance such as cocaine. After experiencing both of these stressors, these groups of rat often 
showed no significant difference in anxiety like behavior compared to the control group, truly 
exemplifying how adaptive a brain can be. Although this study did not find a direct interaction 
with MS and cocaine addiction due to a myriad of complications, the theories underlying the 
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study are worthwhile to investigate further. Addiction and anxiety are two interrelated mental 
health conditions that need to be investigated further in order to better the treatment options of 
both.  
Going forward with this study, other than correcting the possible sources of error in both 
the maternal separation and cocaine exposure, the study would benefit from a biological assay. 
One of the more likely targets would be to examine either cortisol or CRH to at each of the 
behavioral assay testing times. Determining this relationship would allow help definitively 
confirm if early life stress models such as maternal separation have induced a heightened stress 
response. Building from this biological assay, a study cocaine self-administration would be 
useful for determining how early life stress can influence cocaine addiction when the 
administration is controlled by the rats rather than controlled doses delivered in specific 
quantities.   
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